Skip to main content
Clinical Trials/NCT00915291
NCT00915291
Completed
Not Applicable

Sound Prescribing Study - Assessing the Impact of Pharmaceutical Marketing and Promotional Practices on Physician Prescribing

American Medical Association4 sites in 1 country133 target enrollmentMay 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lumbosacral Muscle Strain
Sponsor
American Medical Association
Enrollment
133
Locations
4
Primary Endpoint
Decision to prescribe celecoxib
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The purpose of this study is to determine whether physicians can be educated to better handle inappropriate requests from patients for direct-to-consumer advertised prescription medications.

Detailed Description

Since changes in FDA regulation direct-to-consumer advertising (DTCA), pharmaceutical companies have expended increasing resources to market their products to the public. This has led to increased awareness of diseases and potential treatments, but it has also created more public demand for medications that may not be appropriate for a patient's clinical presentation. This study aims to provide physicians with the knowledge and skills required to help them address inappropriate DTCA medication requests from patients.

Registry
clinicaltrials.gov
Start Date
May 2007
End Date
October 2008
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Resident physicians in internal medicine or family medicine specialties at participating study sites

Exclusion Criteria

  • Completed less than 10 months of residency

Outcomes

Primary Outcomes

Decision to prescribe celecoxib

Study Sites (4)

Loading locations...

Similar Trials